NCT05874908

Brief Summary

Acute head and neck infections cause significant pain and discomfort for patients and impact on their quality of life. Effective antibiotic and surgical treatments have been developed for these infections but they are still able to develop into life-threatening diseases such as meningitis and sepsis. The direct cause of acute head and neck infections is often unknown but it has been suggested that they are due to a disturbance of the normal bacterial growing in the mouth or are from dental origin. The most common microorganisms identified from these infections in published studies are a group of bacteria known as viridans group streptococci (VGS). There are over 30 individual species of bacteria in the viridans group and VGS are difficult to identify to the level of a single species because of their variability. There is a lack of species identification within the hospital setting and this project aims to gain a deeper understanding of the microorganisms causing acute head and neck infections, focusing on identification of individual species of VGS bacteria. The investigators will analyse bacterial DNA to determine which species have been identified and will also look at patient data and clinical outcomes (eg. length of hospital stay) to determine if the species causing the infection has any effect on patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 25, 2023

Completed
1.8 years until next milestone

Study Start

First participant enrolled

March 3, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2026

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

1.1 years

First QC Date

May 8, 2023

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identification of Streptococci Species

    Identification by DNA analysis of ribosomal ribonucleic acid (rRNA) genes and biochemical testing.

    4 years

Secondary Outcomes (6)

  • Patient Characteristics

    4 Years

  • Patient Characteristics

    4 Years

  • Patient Characteristics

    4 Years

  • Clinical Outcomes

    4 Years

  • Clinical Outcomes

    4 Years

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with acute head and neck infections at Northampton General Hospital.

You may qualify if:

  • Over the age of 18
  • Suffering with acute head and neck infection of Streptococci.
  • Samples must come from Northampton General Hospital.
  • Consent to participate in research with at least 24 hours of consideration.

You may not qualify if:

  • Age \<18 years.
  • Samples from other National Health Service (NHS) hospitals.
  • Infections from other areas of the body.
  • Infection identified as caused by non-streptococcal bacteria.
  • Chosen not to participate in research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Northampton

Northampton, NN1 5PH, United Kingdom

Location

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Bacterial isolates from pus swabs.

Study Officials

  • Alexandra Woodacre, PhD, BSc

    University of Northampton

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 8, 2023

First Posted

May 25, 2023

Study Start

March 3, 2025

Primary Completion

April 19, 2026

Study Completion

April 19, 2026

Last Updated

February 28, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Only share pseudonymised data of participant/clinical outcomes.

Shared Documents
STUDY PROTOCOL
Time Frame
October 2025
More information

Locations